Wireless Charging Coils for Medical Implants: Design Guide for Biocompatibility, SAR Compliance, and Miniaturized WPT

Quick Answer

Wireless charging coils for medical implants — including cochlear implants, cardiac devices, implantable neurostimulators, and biosensors — must be specified for biocompatibility (ISO 10993), specific absorption rate (SAR limits per IEC 62233 / IEEE C95.1), operating frequency (typically 100–400 kHz for transcutaneous energy transfer), and coil geometry sized for the implant envelope. These requirements are categorically different from consumer wireless charging and must be addressed in the coil design before any other performance target.

The wireless charging system that keeps implantable medical devices powered is one of the most critical — and most constrained — subsystems in the implant design. A poorly specified charging coil means re-operation to replace a battery-depleted device, or worse, thermal injury from excessive tissue heating during charging.

1. How Transcutaneous Energy Transfer (TET) Works

In a TET system, an external transmitter coil (worn on the skin surface) transfers power inductively through intact skin to a receiver coil implanted beneath the tissue. The implanted receiver charges the device's battery or powers it directly.

The lower coupling coefficient through tissue means the implant TET system must operate with higher Q coils and tighter frequency control than consumer charging — or efficiency drops to unusable levels.

2. Biocompatibility: The Non-Negotiable Starting Point

Before any electrical parameter can be finalized, the implanted coil must pass biocompatibility assessment per ISO 10993-1. For a coil in permanent contact with tissue:

Every material in contact with tissue must be assessed — not just the coil wire, but the bobbin material, encapsulant, adhesive, and any surface coating.

2.1 Biocompatible Materials for Implant Coils

• PTFE-insulated wire — excellent biocompatibility, rated per ISO 10993, chemical inertness. Widely used in implant-grade coil windings.
• Parylene-coated wire — thin conformal coating (2–50 μm) with ISO 10993 pass history; used where PTFE bulk insulation would consume too much space.
• Silicone-insulated wire — flexible, biocompatible, used in cochlear implant and neurostimulator coils.
• Encapsulant: Medical-grade silicone elastomer (Class VI USP, ISO 10993 tested) is the standard. Do not assume standard electronics epoxies are biocompatible.
• Core material: Air-core coils eliminate ferrite biocompatibility concerns entirely. When ferrite backing is used, it must be encapsulated to prevent direct tissue contact and tested for particulate release.

3. SAR Compliance: Preventing Tissue Heating

Specific Absorption Rate (SAR) quantifies the rate at which electromagnetic energy is absorbed by body tissue (W/kg). Regulatory limits:

• IEEE C95.1 / ICNIRP: 1.6 W/kg averaged over any 10 g of tissue (head and trunk)
• FDA guidance: Implanted RF-powered devices must demonstrate SAR compliance as part of the 510(k) or PMA submission

SAR depends on operating frequency (higher = more heating), coil geometry and position, transmitted power, and the anatomical tissue model used. FDA requires SAR evaluated using anatomical tissue models, not just free-space calculations.

3.1 Design Strategies to Stay Within SAR Limits

• Minimize operating frequency: Most implant TET systems operate at 100–400 kHz. Lower frequency reduces tissue heating but requires larger coil inductance.
• Maximize system efficiency: Target overall TET efficiency >70% at worst-case misalignment — requiring Q >100 on both Tx and Rx coils.
• Use resonant topology: Series-series or series-parallel resonant compensation maximizes power transfer for a given coil geometry and coupling coefficient through tissue.
• Coil shielding on the external Tx: A ferrite backing on the body-worn Tx coil directs field toward the skin surface and reduces lateral field spread.

4. Coil Design Parameters for Implant TET

4.1 Operating Frequency

Most implant TET systems operate between 100 kHz and 400 kHz. The operating frequency is typically set by the system IC (implant power management IC) — confirm the IC's resonant frequency requirement before specifying coil inductance. Lower frequency (100–200 kHz) gives lower SAR and better depth penetration; higher frequency (200–400 kHz) enables smaller coil geometry.

4.2 Inductance and Q Factor

Power transferred in a TET system scales with: P ∝ k² × Q_tx × Q_rx × f

Since k through tissue is inherently low (0.05–0.3), achieving adequate power transfer requires maximizing Q:

• Target Q_rx > 100 at the operating frequency (implanted coil)
• Target Q_tx > 80 at the operating frequency (external coil)

Tissue loading reduces Q by 10–40% compared to free-air measurements. Always characterize coil Q in a tissue phantom (saline or gel with appropriate conductivity ~0.5 S/m) before finalizing the design.

4.3 Coil Geometry for Common Implant Types

For coils below 15 mm OD, achieving Q >100 requires custom winding — catalog coils at these sizes rarely specify Q at 100–400 kHz.

4.4 Wire Specification

For operating frequencies above 100 kHz, always use Litz wire. Single-strand wire at 200 kHz+ has skin depth ~150 μm — a 0.3 mm wire operates only on its surface, wasting 75% of its cross-section.

5. Regulatory Considerations

5.1 FDA Regulatory Pathway

FDA submission (510(k) or PMA) requires: biocompatibility data (ISO 10993 test reports) for all implanted materials; SAR analysis (computational + phantom measurement) per IEEE C95.1; electrical characterization: impedance vs. frequency, Q vs. temperature, coupling coefficient vs. misalignment; reliability testing: 10-year fatigue simulation, thermal cycling, accelerated aging; sterility and bioburden documentation.

5.2 EU MDR (Medical Device Regulation 2017/745)

Technical documentation must include: risk management per ISO 14971; biocompatibility evaluation per ISO 10993-1; EMC testing per IEC 60601-1-2; usability engineering per IEC 62366-1.

5.3 IEC 60601-1 Applied Parts

If the external (body-worn) Tx coil is classified as an applied part under IEC 60601-1, it must meet reinforced insulation requirements and patient leakage current limits for Type CF (cardiac floating) or Type BF (body floating) equipment.

6. Frequently Asked Questions

Q: Why can't I use a standard Qi wireless charging coil for a medical implant?
A: Standard Qi coils use enameled copper wire (not biocompatible), standard ferrite backing (not ISO 10993 assessed), and are designed for air-gap coupling — not through 5–25 mm of lossy tissue. The Q, inductance, and SAR characteristics of a consumer coil are not optimized for transcutaneous energy transfer. No regulatory authority will accept a consumer Qi coil in an implanted device without full ISO 10993 testing and SAR analysis.

Q: What Q factor is achievable for an implanted coil surrounded by tissue?
A: Free-air Q of an implant coil design might be 150–200 at 200 kHz. In a tissue phantom (conductivity ~0.5 S/m, representative of muscle), tissue loading typically reduces Q by 20–40%, to 90–150. Design your TET system for the in-tissue Q, not the free-air Q. Always measure Q in a validated tissue phantom before finalizing the resonant capacitor values.

Q: How do I handle misalignment between the external Tx and implanted Rx coils?
A: Misalignment reduces k by 30–60% for a 10 mm lateral offset on a 25 mm coil. Two approaches: (1) design for worst-case alignment — ensure adequate power at maximum expected offset (typically ±15 mm lateral, ±30° angular); (2) use a closed-loop power control IC that adjusts Tx power as k varies. Some systems combine a small permanent magnet alignment aid in both Tx and Rx to reduce misalignment.

Q: What encapsulation process is used for implant coils?
A: Medical-grade liquid silicone injection molding (LSR) or silicone dip-coating are standard. The coil is placed in a mold, and medical-grade silicone (Class VI USP, ISO 10993 tested) is injected under vacuum to ensure void-free coverage. A minimum encapsulation wall thickness of 0.3–0.5 mm is typical for long-term implants.

Q: How long must an implant TET coil last without replacement?
A: Design life for most implantable medical devices is 10–15 years. The coil must maintain its electrical properties (inductance within ±5%, Q within ±20%) through: 10-year saline immersion, 10 million flexion cycles, and thermal cycling. Accelerated aging per ISO 10993-13 and ASTM F1980 demonstrates long-term stability in compressed test timelines.

7. Implant TET Coil Specification Checklist

• Operating frequency confirmed with implant power management IC vendor
• Target inductance calculated for resonant matching at operating frequency
• Q factor target set (>100 in tissue) and measurement phantom defined
• Wire material confirmed: PTFE-insulated, Parylene-coated Litz, or silicone-insulated
• Litz wire specified for operating frequency >100 kHz
• Encapsulant confirmed: medical-grade silicone (Class VI USP, ISO 10993 tested)
• ISO 10993-1 test plan defined for all implanted materials
• SAR analysis plan defined (computational model + tissue phantom measurement)
• Coil OD and thickness confirmed within implant envelope
• Ferrite backing: biocompatibility tested and particulate containment validated (if used)
• In-tissue Q measurement protocol confirmed (tissue phantom, conductivity spec)
• Misalignment tolerance defined: maximum lateral offset, angular offset
• Mechanical fatigue test plan: flexion cycles, saline immersion, accelerated aging
• Regulatory pathway confirmed: FDA 510(k)/PMA, EU MDR, or combined

About Chengpin Technology

Chengpin Technology designs and manufactures custom wireless charging coils for medical device OEM applications, including transcutaneous energy transfer (TET) coils for implantable neurostimulators, cardiac devices, cochlear implants, and biosensors. Our engineering team works from your system IC reference design and implant envelope constraints to deliver custom-wound coils with medical-grade wire and encapsulation, full ISO 10993 material documentation, and characterized Q vs. frequency data in tissue phantom.

Custom medical implant coil capabilities: Coil OD 5–80 mm | Operating frequency 50 kHz – 1 MHz | Wire: PTFE-insulated, Parylene-coated Litz, silicone-insulated (all ISO 10993 assessed) | Encapsulation: medical-grade silicone (Class VI USP), void-free vacuum process | Lead time: prototype 10–21 days; production 6–8 weeks.

Contact us with your implant TET coil specification — we will provide a technical review and ISO 10993 material status within 48 hours.

References: ISO 10993-1 | ISO 10993-5 | ISO 10993-6 | ISO 10993-13 | IEEE C95.1 | IEC 60601-1 | EU MDR 2017/745